Power W J, Hillery M P, Benedict-Smith A, Collum L M
Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Br J Ophthalmol. 1992 Dec;76(12):711-3. doi: 10.1136/bjo.76.12.711.
Thirty patients with first episode disciform keratitis and with no previous steroid exposure were randomly assigned to double blind treatment with 3% acyclovir ointment and 0.1% betamethasone (Betnesol) drops or acyclovir ointment and matching placebo. In the steroid group 14 of the 15 patients healed in a mean time of 21.8 days. In the placebo group eight of the 13 patients healed in a mean time of 34.5 days. The difference in mean healing time between the two groups was significant (p < 0.05). The cumulative rate of healing was also quicker in the steroid group when compared with the placebo group (p < 0.001). Other clinical parameters improved more favourably in the combination treatment group. Four patients, two in either group, experienced a mild transient punctate epitheliopathy, but no other serious adverse effects were noted. There has been no significant difference in the recurrence rate between the two groups after a mean follow-up period of approximately 3 years.
30例首次发作的盘状角膜炎患者,且此前未使用过类固醇,被随机分配接受双盲治疗,一组使用3%阿昔洛韦眼膏和0.1%倍他米松(倍他索)滴眼液,另一组使用阿昔洛韦眼膏和匹配的安慰剂。在类固醇组中,15例患者中有14例在平均21.8天内愈合。在安慰剂组中,13例患者中有8例在平均34.5天内愈合。两组之间的平均愈合时间差异显著(p<0.05)。与安慰剂组相比,类固醇组的累积愈合率也更快(p<0.001)。联合治疗组的其他临床参数改善更明显。两组各有2例患者出现轻度短暂性点状上皮病变,但未观察到其他严重不良反应。在平均约3年的随访期后,两组之间的复发率没有显著差异。